Literature DB >> 11951132

Kasabach-merritt syndrome.

Sheilagh Maguiness1, Lyn Guenther.   

Abstract

BACKGROUND: Kasabach-Merritt syndrome (KMS) is a consumptive coagulopathy associated with the presence of a large vascular lesion. It is often a frustrating condition to treat and it carries a high mortality rate. There are currently no known treatment guidelines. Kasabach-Merritt syndrome is associated with kaposiform hemangioendothelioma (KHE) and tufted angioma (TA); these lesions, when associated with KMS, are locally invasive, aggressive vascular tumors. Treatment options include supportive care, local therapies, and drug and surgical management. In most recent case reports, a multimodal approach to therapy is taken. OBJECTIVE AND
CONCLUSION: The objective of this article is to provide a comprehensive review of KMS and give an up-to-date summary of treatment options. The clinical presentation, laboratory findings, vascular pathology, and pathophysiology will also be discussed.

Entities:  

Mesh:

Year:  2002        PMID: 11951132     DOI: 10.1177/120347540200600405

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  13 in total

1.  Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery.

Authors:  Run-song Jiang; Rong Hu
Journal:  Int J Clin Oncol       Date:  2011-09-28       Impact factor: 3.402

2.  Vincristine-resistant Kasabach-Merritt phenomenon successfully treated with low-dose radiotherapy.

Authors:  Yuko Watanabe; Masaei Onuma; Chung Y Looi; Yuka Saito; Hiroshi Kitazawa; Hidetaka Niizuma; Takeshi Rikiishi; Osamu Sakamoto; Yoji Sasahara; Satoru Kumaki; Mika Watanabe; Shigeko Ushio; Shigeru Tsuchiya
Journal:  Int J Hematol       Date:  2010-12-15       Impact factor: 2.490

Review 3.  [Dermatologic aspects of anticoagulation].

Authors:  V Meyer; S W Schneider; T Görge
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

4.  Kasabach - Merritt syndrome: A case report.

Authors:  Nader M Osman
Journal:  Sudan J Paediatr       Date:  2013

5.  Kasabach-Merritt syndrome combined with hypercalcemia: A case report.

Authors:  Runying Zou; Fang Peng; Tian Yu; Saizhen Zeng; Yalan You; Keke Chen; Hui Zou; Xin Tian; Chengguang Zhu; Xiangling He
Journal:  Exp Ther Med       Date:  2017-10-18       Impact factor: 2.447

Review 6.  Tumors of the hand.

Authors:  Andreas F Mavrogenis; Georgios N Panagopoulos; Andrea Angelini; Jan Lesenský; Christos Vottis; Panayiotis D Megaloikonomos; Zinon T Kokkalis; Vasilios Kontogeorgakos; Pietro Ruggieri; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-05

7.  Neuroembolization of metastatic Merkel cell cancer to the face for treatment of Kasabach-Merritt syndrome.

Authors:  Jason Huang Lee; Sudipta Roychowdhury; Michael J Nissenblatt
Journal:  BMJ Case Rep       Date:  2013-01-17

8.  Kasabach-Merritt phenomenon with cellulitis in infant.

Authors:  Ariyati Yosi; Abdullah Afif Siregar; Yasmine Siregar; Widyaningsih Oentari
Journal:  BMJ Case Rep       Date:  2020-09-15

9.  Successful treatment of kasabach-merritt syndrome with vincristine and surgery: a case report and review of literature.

Authors:  Kotb Abass; Hekma Saad; Mostafa Kherala; Alaa A Abd-Elsayed
Journal:  Cases J       Date:  2008-05-23

10.  Spontaneous subdural hematoma associated with kasabach-merritt syndrome: a case report.

Authors:  Ufuk Emre; Ayla Gökmen; Banu Ozen; Enes Demiryürek; Sanser Gül; Dilvin Gökçe
Journal:  Turk J Haematol       Date:  2012-10-05       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.